(Q34495463)

2 August 2017

1 reference

title

Targeting angiogenesis with integrative cancer therapies (English)

1 reference

2 August 2017

1 reference

Donald R Yance

1

1 reference

2 August 2017

Stephen M Sagar

series ordinal

2

1 reference

2 August 2017

publication date

1 March 2006

1 reference

Integrative Cancer Therapies

2 August 2017

published in

1 reference

2 August 2017

volume

5

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

9-29

1 reference

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Fundamental Concepts of the Angiogenic Process

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Angiogenesis inhibition: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Is the relationship between angiogenesis and metastasis in breast cancer real?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Clinical translation of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Cancer metastasis: A product of tumor-host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Redefining the target: chemotherapeutics as antiangiogenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Can a rational design for metronomic chemotherapy dosing be devised?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Tumor angiogenesis: a potential target in cancer control by phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Role of the tumor microenvironment in mediating response to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Investigation of novel fumagillin analogues as angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Antiangiogenic agents: studies on fumagillin and curcumin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Approaches to preclinical screening of antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Modelling approaches for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Curcumin: a new radio-sensitizer of squamous cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Curcumin exerts multiple suppressive effects on human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Molecular mechanisms of anti-angiogenic effect of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

PC-SPES: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Resveratrol and quercetin inhibit angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Anti-angiogenic property of edible berries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Upregulation of oxidant-induced VEGF expression in cultured keratinocytes by a grape seed proanthocyanidin extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

The inhibitory effects of aqueous extract of Magnolia officinalis on human mesangial cell proliferation by regulation of platelet-derived growth factor-BB and transforming growth factor-beta1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Honokiol: a potent chemotherapy candidate for human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Angiogenesis inhibited by drinking tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Phase I trial of oral green tea extract in adult patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Ginkgo biloba extracts and cancer: a research area in its infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Downregulation of COX-2 and iNOS by amentoflavone and quercetin in A549 human lung adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Polysaccharide isolated from Poria cocos sclerotium induces NF-kappaB/Rel activation and iNOS expression through the activation of p38 kinase in murine macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

A novel DNA topoisomerase inhibitor: dehydroebriconic acid, one of the lanostane-type triterpene acids from Poria cocos

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Antiproliferative and differentiating effects of polysaccharide fraction from fu-ling (Poria cocos) on human leukemic U937 and HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Antitumor activities of heteropolysaccharides of Poria cocos mycelia from different strains and culture media

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

[6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

High dietary iron and copper and risk of colorectal cancer: a case-control study in Burgundy, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Shark cartilage as source of antiangiogenic compounds: from basic to clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Shark cartilage extracts as antiangiogenic agents: smart drinks or bitter pills?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Anticoagulant drugs increase natural killer cell activity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Squalamine: a polyvalent drug of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Obesity, adipocytokines, and insulin resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

IkappaBalphaM suppresses angiogenesis and tumorigenesis promoted by a constitutively active mutant EGFR in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Epidermal growth factor-related peptides and their receptors in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

EGFR and cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

The epidermal growth factor receptor and its inhibition in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

The effect of aloe emodin on the proliferation of a new merkel carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Dietary linoleic acid-stimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Omega-3 fatty acids as cancer chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Cyclooxygenase-2: a therapeutic target in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated prot

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Transcription factors and mitogen-activated protein kinases as molecular targets for chemoprevention with anti-inflammatory phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Signaling pathways in apoptosis as potential targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Isoflavones, substances with multi-biological and clinical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

BAX-dependent transport of cytochrome c reconstituted in pure liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Molecular mechanisms of echinocystic acid-induced apoptosis in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Echinocystic acid induces apoptosis in HL-60 cells through mitochondria-mediated death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Down-regulation of cyclooxygenase-2 and telomerase activity by beta-lapachone in human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Resistance in the anti-angiogenic era: nay-saying or a word of caution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Review article: angiogenesis soluble factors as liver disease markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

A surrogate marker to monitor angiogenesis at last

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Preclinical MRI experience in imaging angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285562

21 January 2018

Identifiers

DOI

10.1177/1534735405285562

1 reference

2 August 2017

1 reference